• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮质类固醇治疗后乙肝表面抗原过度产生与免疫母细胞淋巴瘤的发生

Excessive hepatitis-B surface antigen production after corticosteroids and the development of immunoblastic lymphoma.

作者信息

Ras E, Michaeli J, Rosenmann E, Popovtzer M M, Polliack A, Shouval D

机构信息

Department of Medicine, Mount Scopus, Jerusalem, Israel.

出版信息

Leuk Lymphoma. 1993 Jun;10(3):241-4. doi: 10.3109/10428199309145890.

DOI:10.3109/10428199309145890
PMID:8220124
Abstract

The development of B-cell immunoblastic lymphoma in a 51 year old patient with hepatitis B virus related immune complex nephritis is described. The lymphoma was diagnosed eleven months after the administration of high dose corticosteroids which resulted in a striking increase in the HBsAg serum titer up to 1:1,000,000. This unusual association raises a number of interesting questions regarding the link between immune complex nephritis and immunoblastic lymphoma. The significance of corticosteroid therapy leading to excessive HBsAg secretion and the role played by this intense antigenic stimulation in the pathogenesis of lymphoma in this particular patient are also discussed.

摘要

本文描述了一名51岁患有乙型肝炎病毒相关免疫复合物性肾炎的患者发生B细胞免疫母细胞性淋巴瘤的病例。该淋巴瘤在给予大剂量皮质类固醇治疗11个月后被诊断出来,这导致血清HBsAg滴度显著升高至1:1,000,000。这种不寻常的关联引发了一些关于免疫复合物性肾炎与免疫母细胞性淋巴瘤之间联系的有趣问题。还讨论了皮质类固醇治疗导致HBsAg分泌过多的意义以及这种强烈抗原刺激在该特定患者淋巴瘤发病机制中所起的作用。

相似文献

1
Excessive hepatitis-B surface antigen production after corticosteroids and the development of immunoblastic lymphoma.皮质类固醇治疗后乙肝表面抗原过度产生与免疫母细胞淋巴瘤的发生
Leuk Lymphoma. 1993 Jun;10(3):241-4. doi: 10.3109/10428199309145890.
2
Improvement of immune-complex nephritis associated with hepatitis B surface antigen excess.乙肝表面抗原过量相关免疫复合物性肾炎的改善
Am J Nephrol. 1989;9(2):162-6. doi: 10.1159/000167957.
3
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations.一名乙肝表面抗原阴性、乙肝核心抗体阳性的淋巴瘤患者化疗后乙肝致命再激活:对未来预防建议的潜在影响
Leuk Lymphoma. 2005 Jul;46(7):1085-9. doi: 10.1080/10428190500062932.
4
Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.乙肝表面抗原阴性/乙肝核心抗体阳性患者接受利妥昔单抗联合化疗而未常规进行抗病毒预防时乙型肝炎病毒(HBV)再激活的风险。
Ann Hematol. 2011 Oct;90(10):1219-23. doi: 10.1007/s00277-011-1241-0. Epub 2011 Apr 26.
5
Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.一名非霍奇金淋巴瘤患者在接受化疗前乙肝表面抗原阴性且核心抗体阳性,出现致命性乙肝病毒再激活。
J Clin Gastroenterol. 2009 May-Jun;43(5):496-8. doi: 10.1097/MCG.0b013e3181945942.
6
Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients.基于利妥昔单抗方案治疗后乙肝病毒再激活:HBsAg阳性和HBsAg阴性患者的严重并发症
Ann Hematol. 2010 Mar;89(3):255-62. doi: 10.1007/s00277-009-0806-7. Epub 2009 Aug 21.
7
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.利妥昔单抗治疗的 B 细胞淋巴瘤患者乙型肝炎病毒再激活:亚洲淋巴瘤研究组的分析。
Eur J Cancer. 2013 Nov;49(16):3486-96. doi: 10.1016/j.ejca.2013.07.006. Epub 2013 Aug 1.
8
[B-cell lymphoma developing de novo hepatitis B after salvage therapies including rituximab through seroconversion of surface antibody].[经包括利妥昔单抗在内的挽救性治疗后通过表面抗体血清学转换而新发乙型肝炎的B细胞淋巴瘤]
Rinsho Ketsueki. 2014 Nov;55(11):2283-7.
9
High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma.高滴度抗-HBs 可预防已缓解乙型肝炎患者非霍奇金淋巴瘤患者接受利妥昔单抗治疗相关的病毒再激活。
J Med Virol. 2016 Jun;88(6):1010-7. doi: 10.1002/jmv.24423. Epub 2015 Nov 13.
10
Mycophenolate mofetil use in hepatitis B associated-membranous and membranoproliferative glomerulonephritis induces viral replication.霉酚酸酯用于乙型肝炎相关性膜性和膜增生性肾小球肾炎会诱导病毒复制。
Ann Pharmacother. 2005 Mar;39(3):573. doi: 10.1345/aph.1E419. Epub 2005 Jan 25.

引用本文的文献

1
The role of immunosuppression in lymphoma formation.免疫抑制在淋巴瘤形成中的作用。
Springer Semin Immunopathol. 1998;20(3-4):343-55. doi: 10.1007/BF00838048.
2
[Glomerulonephritis and malignant lymphoma. Mostly men with low-grade lymphoma with various forms of glomerulonephritis].[肾小球肾炎与恶性淋巴瘤。多为患有低度淋巴瘤且伴有各种形式肾小球肾炎的男性]
Med Klin (Munich). 1997 Dec 15;92(12):712-9. doi: 10.1007/BF03044667.
3
Primary hepatic high-grade non-Hodgkin's lymphoma and chronic hepatitis C infection.原发性肝脏高级别非霍奇金淋巴瘤与丙型肝炎慢性感染
Dig Dis Sci. 1997 Nov;42(11):2241-5. doi: 10.1023/a:1018858415936.
4
Hepatitis B virus infection associated with hematopoietic tumors.与造血系统肿瘤相关的乙型肝炎病毒感染
Am J Pathol. 1994 Nov;145(5):1001-7.